According to forecasts, the global molecular imaging industry size is expected to be US$ 5,437.16 million in 2023 and US$ 15,457.48 million by 2033. The market is projected to exhibit a CAGR of 11%. The need for early illness diagnosis is increasing due to the rising incidence of numerous chronic diseases like cancer and other …
Category Archives: Healthcare Trends
Global Multiplex Biomarker Imaging Market Set to Surge at 11.9% CAGR, Driven by Cancer Growth and Personalized Medicine | FMI
The global multiplex biomarker imaging market is poised for explosive growth, reaching an estimated US$ 1,041.7 Million by 2029, according to a recent survey by Future Market Insights (FMI). This represents a significant leap from the US$ 475.2 Million in 2022, translating to a robust 11.9% CAGR. To Remain Ahead of Your Competitors, Request For …
Global Dermal Fillers and Botulinum Toxin Market Projected to Reach US$ 10.5 Billion by 2032, Reports Industry Analysis
The market for dermal fillers and botulinum toxins is on a trajectory for massive expansion, reaching a projected US$ 10.5 billion by 2032, according to industry experts. This represents a significant jump from the market’s US$ 5.9 billion valuation at the end of 2022 and signifies a robust CAGR of 6.1% over the next decade. …
Global Diabetic Macular Edema Market Poised for Steady Growth US$ 4.2 Billion by 2032: Despite Challenges, Driven by Rising Diabetes Rates | FMI
The global diabetic macular edema (DME) market is expected to reach a valuation of US$ 3.7 billion by the end of 2022, with a projected CAGR of 1.2% from 2022 to 2032, reaching a valuation of ~US$ 4.2 billion by the end of the forecast period, according to market research firm FMI. Despite a modest …
Global Farm Animal Pharmaceutical Industry Projected to Reach US$ 29.4 Billion by 2032: FMI
The global farm animal pharmaceutical industry is poised for substantial growth, with projections indicating a significant increase in market size by the end of the decade. According to recent forecasts, the global farm animal pharmaceutical industry is expected to reach a value of US$ 17.2 billion by the close of 2022, with a compound annual …
Global Oral Controlled Release Drug Delivery Technology Industry to climb to an impressive US$ 68.4 Billion by 2032 | FMI
The global oral controlled release drug delivery technology industry is projected to witness a significant surge, growing from US$ 34.1 billion in 2022 to a staggering US$ 68.4 billion by 2032, according to a recent market analysis. This remarkable expansion translates to a robust 7.2% compound annual growth rate (CAGR) over the forecast period. The …
Global MRI-Compatible IV Infusion Pump Systems Market Set to Skyrocket, Reaching US$ 580.3 Million by 2032 | FMI
The global market for MRI-compatible IV infusion pump systems is poised for remarkable growth, projected to reach a staggering worth of US$ 580.3 million by 2032, according to recent market analysis. From its anticipated value of US$ 234.8 million by the end of 2022, this industry is expected to soar at a Compound Annual Growth …
Global Oral Solid Dosage Pharmaceutical Formulation Industry Set to Surge with a Robust 6.4% CAGR by 2032, according to FMI
The global oral solid dosage pharmaceutical formulation industry is poised for remarkable growth, with a projected Compound Annual Growth Rate (CAGR) of 6.4% from 2022 to 2032. According to the latest industry assessments, the estimated market value is expected to reach US$ 1.0 billion by 2032, compared to US$ 555.3 million in 2022. A recent …
Global Medical Bionic Implant and Exoskeleton Market Projected to Reach US$ 1,361.90 Million by 2033 | FMI
The global medical bionic implant and exoskeleton market is poised for substantial growth, with estimates indicating a valuation of US$ 742.0 million by 2023, reflecting a significant increase from the recorded US$ 690.2 million in 2022. The market is projected to witness a robust 6.3% Compound Annual Growth Rate (CAGR) from 2023 to 2033, reaching …
Global Pancreatic Cancer Industry Ready to Hit US$ 7,541.09 Million by 2033 with a Noteworthy CAGR of 13.5% | FMI
In a groundbreaking revelation, Future Market Insights Inc. A renowned healthcare analysis firm has released a comprehensive analysis of the Global Pancreatic Cancer Industry, projecting a valuation of approximately US$ 2,125.57 Million by the end of 2023. The study anticipates an extraordinary Compound Annual Growth Rate (CAGR) of 13.5%, laying the foundation for a significant …